FDA FAQ on Diagnostic Testing for SARS-CoV-2

On March 10, 2020, the Food and Drug Administration (FDA) posted answers to frequently asked questions (FAQs) on Diagnostic Testing for SARS-CoV-2. This LOCS message is to raise awareness about these FDA FAQs among clinical laboratories that could potentially be asked to perform testing. Topics covered include information on Confirmatory testing for presumptive positive results…

Read more

SURVEY ACTIVITY RESUMES WITH FOCUS ON INFECTION PREVENTION AND CONTROL

CMS announced on March 5, 2020 that the majority of deemed status surveys would be suspended due to the threat of COVID-19. This policy has been revised to allow hospital, CAH, and ASC surveys performed by HFAP and other accrediting organizations to resume. The four accreditation organizations (AO) with deeming authority for hospitals (HFAP, DNV,…

Read more

COVID-19 Guidance for Infection Control and Prevention (Patient Triage, Placement and Discharge)

CMS MEMO March 4, 2020 (QSO-20-13) CMS is committed to the protection of patients and residents of healthcare facilities from the spread of infectious disease. This memorandum responds to questions received and provides guidance for hospitals and critical access hospitals (CAHs) in addressing the COVID-19 outbreak and minimizing transmission to other individuals. Specifically, it addresses…

Read more